Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
KRMD
SELLKORU Medical Systems, Inc. · Healthcare · United States · $176M · Avg Vol: $657K/d
COMPANY DESCRIPTION
KORU Medical Systems, Inc. designs, manufactures, and markets innovative medical devices and supplies for subcutaneous infusion, including the FREEDOM Infusion System. The company holds a strong position in the niche market of subcutaneous infusion, offering specialized and patient-friendly solutions that enhance convenience and adherence for chronic care patients. KORU Medical is a specialized healthcare device company, focusing on improving the quality of life for patients requiring regular subcutaneous infusions through its innovative delivery systems.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.9M | 28.5M | 33.6M | 41.1M | 13.8% | 43.3M | 48.7M | 56.9M | 17.7% |
| EPS | -0.19 | -0.30 | -0.13 | -0.06 | — | -0.05 | — | — | — |
| Shares | 45.4M | 45.7M | 46.0M | 46.4M | +2.0% | 45.9M | — | — | — |
| Debt | 4.9M | 4.4M | 4.0M | 3.5M | -10.8% | 3.4M | — | — | — |
| Equity | 31.3M | 20.4M | 16.8M | 17.0M | -18.4% | — | — | — | — |
| Op CF | -5.4M | -4.9M | -0.3M | 0.5M | — | 0.7M | — | — | — |
| Inv CF | -2.8M | -0.8M | -1.3M | -0.9M | — | — | — | — | — |
| Fin CF | 0.3M | -0.2M | -0.2M | -0.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of KRMD are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| KRMD | KORU Medical Systems, Inc.(you) | $176M | 27 | SELL |
| MBOT | Microbot Medical Inc. | $115M | 19 | STRONG SELL |
| STXS | Stereotaxis, Inc. | $129M | 6 | STRONG SELL |
| OSUR | OraSure Technologies, Inc. | $273M | 48 | HOLD |
| DXR | Daxor Corporation | $61M | 44 | HOLD |
| SMTI | Sanara MedTech Inc. | $234M | 60 | HOLD |
| KMTS | Kestra Medical Technologies, Ltd. | $1.2B | 23 | SELL |
| EMBC | Embecta Corp. | $195M | 74 | BUY |
| PLSE | Pulse Biosciences, Inc. | $2.1B | 24 | SELL |
| ANGO | AngioDynamics, Inc. | $562M | 58 | HOLD |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%